Preferred Label : toripalimab;
MeSH synonym : toripalimab-tpzi;
UNII : 8JXN261VVA;
Origin ID : C000656314;
UMLS CUI : C4763386;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/toripalimab
2026
false
false
false
France
French
risk management
toripalimab
toripalimab
antibodies, monoclonal, humanized
drug information
patients guideline
immune system diseases
Immune Checkpoint Inhibitors
infusions, intravenous
---
https://www.ema.europa.eu/en/medicines/human/EPAR/loqtorzi
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
toripalimab
toripalimab
Cisplatin/Gemcitabine/Toripalimab Regimen
drug approval
europe
antineoplastic combined chemotherapy protocols
Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitors
toripalimab
adult
Nasopharyngeal Carcinoma
neoplasm recurrence, local
Recurrent Nasopharyngeal Carcinoma
Esophageal Squamous Cell Carcinoma
cisplatin
paclitaxel
Gemcitabine
Unresectable Esophageal Squamous Cell Carcinoma
Recurrent Esophageal Squamous Cell Carcinoma
Metastatic Esophageal Squamous Cell Carcinoma
Advanced Esophageal Squamous Cell Carcinoma
infusions, intravenous
product surveillance, postmarketing
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
drug interactions
pregnancy
breast feeding
programmed cell death 1 receptor
---